MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Initial Results from the Zambian Epidemiology of Parkinson’s disease and Healthcare Registry (ZEPHyR)

    T. Lee, O. Siddiqi, M. Atadzhanov, D. Saylor, J. Fleisher (Aurora, CO, USA)

    Objective: To describe the launch and preliminary findings of ZEPHyR, the first Parkinson’s Disease (PD) registry in Zambia. Background: PD is the second most common…
  • MDS Virtual Congress 2020

    Estimation of latent class mixed models towards discovery of subgroup trajectories of MDS-UPDRS part II, part III, and ambulatory capacity in Parkinson’s disease

    C. Venuto, R. Zielinski, G. Smith, M. Javidnia, K. Kieburtz (Rochester, NY, USA)

    Objective: To use latent mixed modeling (LMM) for the identification of subgroups of people living with Parkinson’s disease (PD) who have statistically distinct trajectories of…
  • MDS Virtual Congress 2020

    Atypical alternating hemiplegia of childhood in Korea: A case report

    C. Shin, H. Kim, B. Jeon (Daejeon, Republic of Korea)

    Objective: To report an atypical case of alternating hemiplegia of childhood (AHC), which has not yet been reported in Korea. Background: The ATP1A3 gene pathologic…
  • MDS Virtual Congress 2020

    Epidemiology of Huntington’s Disease (HD) in the US Medicaid Population

    A. Exuzides, S. Reddy, E. Chang, C. Paydar, G. Yohrling (South San Francisco, CA, USA)

    Objective: To estimate the current prevalence of Huntington’s disease (HD) among Medicaid beneficiaries in the United States (US). Background: HD is a genetic, progressive, neurodegenerative…
  • MDS Virtual Congress 2020

    Development of a time-to-event endpoint for use in premanifest Huntington’s disease (HD) clinical trials

    S. Rossomanno, H. Guthrie, E.J Wild, S.A Schobel, L. Boak, D. Trundell (Basel, Switzerland)

    Objective: To develop and evaluate a time-to-event endpoint to measure disease progression in individuals with premanifest HD. Background: HD is typically diagnosed between the ages…
  • MDS Virtual Congress 2020

    Development of Hypertrophic Olivary Degeneration Following Pontine Hemorrhage

    K. Bird, M.H Saint-Hilaire, G. Curiale, S. O'Shea (Boston, MA, USA)

    Objective: To increase awareness of the late post-stroke movement disorder associated with hypertrophic olivary degeneration. Background: A 65-year-old man with a past medical history significant…
  • MDS Virtual Congress 2020

    Visual cortex involvement in the familial cortical myoclonic tremor with epilepsy type 1: a resting state-fMRI with regional homogeneity analysis

    B. Wang, H.T Wang, Z.D Chen, W. Luo (Hangzhou, China)

    Objective: The purpose of current study was to investigate regional synchronization of the whole brain in patients with familial cortical myoclonic tremor with epilepsy (FCMTE)…
  • MDS Virtual Congress 2020

    Parkinson’s Disease and the Law: Motor and Non-Motor Determinants in Medical Courts Cases

    P. Amami, D. Ziemele, A. Albanese (Rozzano, Italy)

    Objective: We reviewed the legal issues involving PD patients in Italy and United Kingdom and correlated these findings with the clinical condition of the involved…
  • MDS Virtual Congress 2020

    Patient survey on personal preferences and choices regarding Advance Care Planning(ACP) in Parkinson’s Disease(PD)

    M. Khwaja, A. Chatterjee (Reading, United Kingdom)

    Objective: Understanding patients' choices and preferences in the advanced stage Parkinson’s disease. Background: Surveys of patients' experiences are increasingly recognized as an essential part of…
  • MDS Virtual Congress 2020

    Efficacy of unilateral thalamotomy by MRgFUS in essential tremor and Parkinson’s disease in a large cohort of patients

    M.C Rodríguez Oroz, O. Parras, A. Gorospe, I. Aviles, P. Manrique, L. Gonzalez, J. Guridi (Navarre, Spain)

    Objective: To evaluate the efficacy and adverse events of unilateral lesions of the ventral intermediate (VIM) nucleus of the thalamus (thalamotomy) by magnetic resonance guided…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley